| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 04/06/2000 | WO2000018929A2 Paramyxovirus vaccines |
| 04/06/2000 | WO2000018925A1 Gene expressed in prostate cancer |
| 04/06/2000 | WO2000018919A1 Human kinesin-like motor protein |
| 04/06/2000 | WO2000018918A2 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | WO2000018910A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | WO2000018906A2 Shuffling of codon altered genes |
| 04/06/2000 | WO2000018896A1 Cloning and recombinant production of polistinae venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/06/2000 | WO2000018821A1 Biodegradable low molecular weight triblock polyester polyethylene glycol copolymers having reverse thermal gelation properties |
| 04/06/2000 | WO2000018804A1 Tie2 agonist antibodies |
| 04/06/2000 | WO2000018803A2 Antibodies to mammalian langerhans cell antigen and their uses |
| 04/06/2000 | WO2000018801A2 Ncam binding compounds |
| 04/06/2000 | WO2000018797A1 Map |
| 04/06/2000 | WO2000018795A2 Compositions and methods for wt1 specific immunotherapy |
| 04/06/2000 | WO2000018794A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | WO2000018791A1 Ligand presenting assembly (lpa), method of preparation and uses thereof |
| 04/06/2000 | WO2000018783A1 Mammaglobin, a secreted mammary-specific breast cancer protein |
| 04/06/2000 | WO2000018438A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/06/2000 | WO2000018437A1 Tie2 antagonist antibodies |
| 04/06/2000 | WO2000018436A1 Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 04/06/2000 | WO2000018435A1 Time-staggered utilization of tumor cells in combination with intact antibodies for immunization |
| 04/06/2000 | WO2000018434A1 Mutant cholera holotoxin as an adjuvant |
| 04/06/2000 | WO2000018433A2 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
| 04/06/2000 | WO2000018432A1 Carbohydrate vaccines for viral diseases |
| 04/06/2000 | WO2000018431A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
| 04/06/2000 | WO2000018430A2 Live virus vaccines to protect primates from hiv-1 infection and disease |
| 04/06/2000 | WO2000018429A2 Vaccine based on attenuated $i(haemophilus somnus) |
| 04/06/2000 | WO2000018427A1 Methods of treating diseased cells |
| 04/06/2000 | WO2000018409A1 Use of certain drugs for treating nerve root injury |
| 04/06/2000 | WO2000018387A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | WO2000018351A2 Aglyco products and methods of use |
| 04/06/2000 | WO2000018336A1 Targeted therapy to a biomedical device |
| 04/06/2000 | WO2000018231A1 Methods for treating or preventing viral infections and associated diseases |
| 04/06/2000 | WO1999067384A3 Prostate cancer-associated genes |
| 04/06/2000 | WO1999064596A3 Proteins regulating gene expression |
| 04/06/2000 | WO1999062941A3 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/06/2000 | WO1999061626A3 Human hydrolase homologs: n-terminal asparagine amidohydrolase, glycosyl hydrolase, glucohydrolase, biotinidase, and n-acetylglucosamine 6-p deacetylase |
| 04/06/2000 | WO1999061618A3 Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof |
| 04/06/2000 | WO1999061453A3 priA |
| 04/06/2000 | WO1999061056A3 Methods and products for inducing mucosal immunity |
| 04/06/2000 | WO1999059608A3 Osteoporosis treatment |
| 04/06/2000 | WO1999058683A3 BASB029 POLYNUCLEOTIDE(S) AND POLYPEPTIDES FROM $i(NEISSERIA MENINGITIDIS) |
| 04/06/2000 | WO1999055730A3 Polyepitope carrier protein |
| 04/06/2000 | WO1999054706A3 Method of treating interstitial cystitis with recombinant hb-egf |
| 04/06/2000 | WO1999051748A9 Fusion proteins of mycobacterium tuberculosis antigens and their uses |
| 04/06/2000 | WO1999040113A3 Lipopeptides containing an interferon fragment and uses thereof in pharmaceutical compositions |
| 04/06/2000 | CA2794705A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | CA2714449A1 Use of certain drugs for treating nerve root injury |
| 04/06/2000 | CA2368856A1 Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen |
| 04/06/2000 | CA2346061A1 Carbohydrate vaccines for viral diseases |
| 04/06/2000 | CA2345978A1 Chemokine receptor peptide vaccines for treatment and prevention of diabetes |
| 04/06/2000 | CA2345959A1 Live virus vaccines to protect primates from hiv-1 infection and disease |
| 04/06/2000 | CA2345347A1 Methods for treating or preventing viral infections and associated diseases |
| 04/06/2000 | CA2344766A1 Antibodies to mammalian langerhans cell antigen and their uses |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | CA2344620A1 Gene expressed in prostate cancer |
| 04/06/2000 | CA2344578A1 Polistinae venom phospholipase |
| 04/06/2000 | CA2344466A1 Use of antigenic complexes of hiv envelope and hla class i antigens as hiv vaccine |
| 04/06/2000 | CA2343975A1 Ncam binding compounds |
| 04/06/2000 | CA2343972A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 04/06/2000 | CA2343939A1 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | CA2343929A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | CA2343811A1 Antibiotic compositions for treatment of the eye, ear and nose |
| 04/06/2000 | CA2343656A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
| 04/06/2000 | CA2341763A1 Antigenic peptides of aglyco 10b and antibodies thereto |
| 04/06/2000 | CA2331335A1 Shuffling of codon altered genes |
| 04/06/2000 | CA2311462A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 04/05/2000 | EP0990703A1 Novel polypeptide, dna encoding the same and use thereof |
| 04/05/2000 | EP0990700A1 H. pylori fermentation process |
| 04/05/2000 | EP0990663A2 Anti-Fas Antibodies |
| 04/05/2000 | EP0990045A1 Reagents and methods useful for detecting diseases of the lung |
| 04/05/2000 | EP0990044A1 A method for in vitro molecular evolution of protein function |
| 04/05/2000 | EP0990041A1 Regulation of transcription in mammalian cells and viral replication by a tetracyclin repressor |
| 04/05/2000 | EP0990037A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 04/05/2000 | EP0990034A1 Anti-gpiib/iiia recombinant antibodies |
| 04/05/2000 | EP0990031A2 Tumor necrosis factor receptor 5 |
| 04/05/2000 | EP0990022A1 $i(TREPONEMA PALLIDUM) POLYNUCLEOTIDES AND SEQUENCES |
| 04/05/2000 | EP0990001A1 Processes for production of immunoglobulin a in milk |
| 04/05/2000 | EP0990000A1 Connective tissue growth factor-3 |
| 04/05/2000 | EP0989999A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 04/05/2000 | EP0989863A2 System for the in vivo delivery and expression of heterologous genes in the bone marrow |
| 04/05/2000 | EP0989861A1 Immunogenic compositions for induction of anti-tumor immunity |
| 04/05/2000 | EP0989860A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 04/05/2000 | EP0989801A2 Transgenic animals expressing human fc receptors |
| 04/05/2000 | EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0741869B1 Specific binding substances for antibodies and their use for immunoassays or vaccines |
| 04/05/2000 | EP0733072B1 Antibody against carcinoembryonic antigen (cea) |
| 04/05/2000 | EP0621874B1 Somatostatin receptors |
| 04/05/2000 | EP0595873B1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/05/2000 | EP0568622B1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 04/05/2000 | EP0479866B1 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus |
| 04/05/2000 | CN1249781A Epitopes of protein pre-M/M of dengue virus, synthetic peptides |
| 04/05/2000 | CN1249433A NANBV diagnostics and vaccine |
| 04/05/2000 | CN1051110C Method and related reagent box for sieve examination of leukemia and its tissue |
| 04/05/2000 | CN1051091C Method for detecting antibodies to hepatitis C virus |
| 04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
| 04/04/2000 | US6046157 Modulation of TGF-β by recombinant TGF-β type II receptor polypeptides |
| 04/04/2000 | US6046044 Cisplatin resistance proteins |